The effect of glucocorticoids on the anxiolytic efficacy of buspirone

J. Haller, C. Leveleki, J. Halász, J. Baranyi, G. Makara

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Rationale: The serotonergic system and the hypothalamus-hypophysis-adrenocortical axis reciprocally influence each other. Therefore, the interaction between stress and serotonergic anxiolytics should be of major concern for both laboratory investigations and clinical treatment. Objectives: We have studied the effects of the serotonergic anxiolytic buspirone in rats in which basal levels of glucocorticoids were low and stable, while acute stress reactions were inhibited or exogenously induced. Methods: Rats were adrenalectomised. Subcutaneous corticosterone pellets maintained basal glucocorticoid concentrations while acute changes were mimicked by corticosterone injections. Anxiety was assessed by the social interaction test. Temporal changes were evaluated by submitting rats to the same manipulations three times at two-day intervals. Results: Buspirone applied to animals with stable and low plasma glucocorticoid concentrations induced a dramatic increase in social interactions. A slight locomotor suppressive effect was also noticed. The effects of buspirone proved to be stable over time in these animals. Acute treatment with corticosterone doubled the locomotor suppressive effects of buspirone and reversed its anxiolytic effects: the buspirone-corticosterone combination was anxiogenic after the first application. During the second and third treatment, the impact of corticosterone on buspirone efficacy gradually decreased, but the combined treatment remained about half as effective in reducing anxiety as buspirone alone.

Original languageEnglish
Pages (from-to)388-394
Number of pages7
JournalPsychopharmacology
Volume157
Issue number4
DOIs
Publication statusPublished - 2001

Fingerprint

Buspirone
Anti-Anxiety Agents
Glucocorticoids
Corticosterone
Interpersonal Relations
Anxiety
Pituitary Gland
Therapeutics
Hypothalamus
Injections

Keywords

  • Anxiety
  • Anxiolytic
  • Buspirone
  • Glucocorticoid
  • Serotonin

ASJC Scopus subject areas

  • Pharmacology

Cite this

The effect of glucocorticoids on the anxiolytic efficacy of buspirone. / Haller, J.; Leveleki, C.; Halász, J.; Baranyi, J.; Makara, G.

In: Psychopharmacology, Vol. 157, No. 4, 2001, p. 388-394.

Research output: Contribution to journalArticle

@article{20c04427722749a7b7bea99200fabb03,
title = "The effect of glucocorticoids on the anxiolytic efficacy of buspirone",
abstract = "Rationale: The serotonergic system and the hypothalamus-hypophysis-adrenocortical axis reciprocally influence each other. Therefore, the interaction between stress and serotonergic anxiolytics should be of major concern for both laboratory investigations and clinical treatment. Objectives: We have studied the effects of the serotonergic anxiolytic buspirone in rats in which basal levels of glucocorticoids were low and stable, while acute stress reactions were inhibited or exogenously induced. Methods: Rats were adrenalectomised. Subcutaneous corticosterone pellets maintained basal glucocorticoid concentrations while acute changes were mimicked by corticosterone injections. Anxiety was assessed by the social interaction test. Temporal changes were evaluated by submitting rats to the same manipulations three times at two-day intervals. Results: Buspirone applied to animals with stable and low plasma glucocorticoid concentrations induced a dramatic increase in social interactions. A slight locomotor suppressive effect was also noticed. The effects of buspirone proved to be stable over time in these animals. Acute treatment with corticosterone doubled the locomotor suppressive effects of buspirone and reversed its anxiolytic effects: the buspirone-corticosterone combination was anxiogenic after the first application. During the second and third treatment, the impact of corticosterone on buspirone efficacy gradually decreased, but the combined treatment remained about half as effective in reducing anxiety as buspirone alone.",
keywords = "Anxiety, Anxiolytic, Buspirone, Glucocorticoid, Serotonin",
author = "J. Haller and C. Leveleki and J. Hal{\'a}sz and J. Baranyi and G. Makara",
year = "2001",
doi = "10.1007/s002130100838",
language = "English",
volume = "157",
pages = "388--394",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - The effect of glucocorticoids on the anxiolytic efficacy of buspirone

AU - Haller, J.

AU - Leveleki, C.

AU - Halász, J.

AU - Baranyi, J.

AU - Makara, G.

PY - 2001

Y1 - 2001

N2 - Rationale: The serotonergic system and the hypothalamus-hypophysis-adrenocortical axis reciprocally influence each other. Therefore, the interaction between stress and serotonergic anxiolytics should be of major concern for both laboratory investigations and clinical treatment. Objectives: We have studied the effects of the serotonergic anxiolytic buspirone in rats in which basal levels of glucocorticoids were low and stable, while acute stress reactions were inhibited or exogenously induced. Methods: Rats were adrenalectomised. Subcutaneous corticosterone pellets maintained basal glucocorticoid concentrations while acute changes were mimicked by corticosterone injections. Anxiety was assessed by the social interaction test. Temporal changes were evaluated by submitting rats to the same manipulations three times at two-day intervals. Results: Buspirone applied to animals with stable and low plasma glucocorticoid concentrations induced a dramatic increase in social interactions. A slight locomotor suppressive effect was also noticed. The effects of buspirone proved to be stable over time in these animals. Acute treatment with corticosterone doubled the locomotor suppressive effects of buspirone and reversed its anxiolytic effects: the buspirone-corticosterone combination was anxiogenic after the first application. During the second and third treatment, the impact of corticosterone on buspirone efficacy gradually decreased, but the combined treatment remained about half as effective in reducing anxiety as buspirone alone.

AB - Rationale: The serotonergic system and the hypothalamus-hypophysis-adrenocortical axis reciprocally influence each other. Therefore, the interaction between stress and serotonergic anxiolytics should be of major concern for both laboratory investigations and clinical treatment. Objectives: We have studied the effects of the serotonergic anxiolytic buspirone in rats in which basal levels of glucocorticoids were low and stable, while acute stress reactions were inhibited or exogenously induced. Methods: Rats were adrenalectomised. Subcutaneous corticosterone pellets maintained basal glucocorticoid concentrations while acute changes were mimicked by corticosterone injections. Anxiety was assessed by the social interaction test. Temporal changes were evaluated by submitting rats to the same manipulations three times at two-day intervals. Results: Buspirone applied to animals with stable and low plasma glucocorticoid concentrations induced a dramatic increase in social interactions. A slight locomotor suppressive effect was also noticed. The effects of buspirone proved to be stable over time in these animals. Acute treatment with corticosterone doubled the locomotor suppressive effects of buspirone and reversed its anxiolytic effects: the buspirone-corticosterone combination was anxiogenic after the first application. During the second and third treatment, the impact of corticosterone on buspirone efficacy gradually decreased, but the combined treatment remained about half as effective in reducing anxiety as buspirone alone.

KW - Anxiety

KW - Anxiolytic

KW - Buspirone

KW - Glucocorticoid

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=0034779991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034779991&partnerID=8YFLogxK

U2 - 10.1007/s002130100838

DO - 10.1007/s002130100838

M3 - Article

C2 - 11605098

AN - SCOPUS:0034779991

VL - 157

SP - 388

EP - 394

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 4

ER -